title: Effect of nizatidine and ranitidine on 24 hour intragastric pH, pepsin, prostaglandin E2 and serum gastrin concentrations in healthy volunteers.
abstract: In order to achieve possible greater therapeutic efficacy, ranitidine 300 mg bid (R2) may be given rather than 300 mg qhs (R1), or nizatidine 300 mg bid (N2) may be given rather than 300 mg qhs (N1). A randomized placebo-controlled crossover study was performed in six healthy volunteers (four males, two females) who ranged in age from 23 to 43 years, comparing R1, R2, N1 and N2 versus placebo (P), measuring 24 h intragastric pH by the aspiration technique, gastric juice pepsin and prostaglandin E2 (PGE2) concentrations, as well as serum gastrin concentrations. In all treatment groups, 24-h intragastric pH was higher than with P; the 24 h and daytime (0800-2200 h) pH was higher with N2 than with N1, but not with R2 versus R1. The percentage pH > or = 3 was greater with N2 than with N1 during the daytime. Night-time (2200-0800 h) and 24 h pepsin concentrations were higher in R2 than in R1, were similar in N1 and N2, and were lower in these treatment groups than in P. The gastric juice PGE2 concentration at night-time, but not at daytime, was increased in the four treatment groups compared with P. Despite the higher pH values at night-time in the treatment groups, the night-time concentrations of serum gastrin were unchanged, and yet during the daytime the higher values of pH were associated with increased gastrin concentrations when R2 or N2 were given, but not with R1 and N1. There was a negative correlation between intragastric juice pH and pepsin concentration during the daytime, and a positive correlation between pH and PGE2 concentration during the night-time. The slopes and y-axis intercepts between pH and pepsin or PGE2 concentrations differed between the placebo and the treatment groups, suggesting that these H2-receptor antagonists may have an effect on lowering pepsin and raising PGE2 concentrations in addition to their effects on pH. As the percentage of time over the 24 h period and night-time periods when the pH was greater than 3 was not different between ranitidine and nizatidine, the two regimens will likely have similar clinical efficacy.
authors.affiliation: Department of Medicine, University of Alberta, Edmonton, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Thompson
authors.forename: P
authors.initials: P
authors.lastname: Kirdeikis
authors.forename: F
authors.initials: F
authors.lastname: Jamali
authors.forename: M
authors.initials: M
authors.lastname: Tavernini
authors.forename: L
authors.initials: L
authors.lastname: Zuk
authors.forename: B
authors.initials: B
authors.lastname: Marriage
authors.forename: I
authors.initials: I
authors.lastname: Simpson
authors.forename: V
authors.initials: V
authors.lastname: Mahachai
mesh_terms: D000328:Adult; D002940:Circadian Rhythm; D015232:Dinoprostone / Q000378:metabolism*; D005260:Female; D005753:Gastric Mucosa / Q000378:metabolism*; D005755:Gastrins / Q000097:blood; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D006801:Humans; D006859:Hydrogen / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D008297:Male; D016567:Nizatidine / Q000494:pharmacology*; D010434:Pepsin A / Q000378:metabolism*; D011899:Ranitidine / Q000494:pharmacology*
chemical_list: D005755:Gastrins; D006635:Histamine H2 Antagonists; D006859:Hydrogen; D011899:Ranitidine; D010434:Pepsin A; D015232:Dinoprostone; D016567:Nizatidine